Javascript must be enabled to continue!
Persistent Activation of CD8+ T-cells Characterizes Prediabetic Twins
View through CrossRef
OBJECTIVE
Elevated circulating levels of activated CD3+ T-cells are characteristic of type I diabetes at diagnosis, and activated CD8+ (cytotoxic/suppressor) T-cells predominate in the islet infiltrate. The aim of this study was to examine the peripheral blood of prediabetic and nondiabetic identical twins of patients with type I diabetes for the presence of activated CD8+ T-cells and by comparing these groups, analyze the relationship of such cells to the development of the disease.
RESEARCH DESIGN AND METHODS
In a 10-year prospective study, blood T-cell subsets (CD3+ total T-cells, CD4+ helper/inducer, and CD8+ cytotoxic/suppressor) were analyzed for evidence of activation (cell surface expression of HLA-DR, CD25) in 18 identical twins of patients with type I diabetes, 8 of whom became diabetic (prediabetic twins), while 10 remained nondiabetic after at least 8 years of follow-up and are now at low risk for type I diabetes. Fifteen healthy individuals were studied as control subjects.
RESULTS
At the beginning and during the study, percentage levels of activated CD3+ HLA-DR+ T-cells were significantly elevated in prediabetic and low-risk twins compared with control subjects (P < 0.005) but remained high only in prediabetic twins (P < 0.005). Both prediabetic and low-risk twins had elevated levels of HLA-DR+ CD4+ T helper cells compared with control subjects throughout the study (P < 0.001), and these remained high in both (P < 0.001 and P < 0.05, respectively). Only prediabetic twins had elevated levels of HLA-DR+ CD8+ T-cells during the study. These were significantly higher than in control subjects (P < 0.005) and low-risk twins (P < 0.05) and remained persistently elevated to diagnosis (P < 0.001). Abnormally elevated levels of HLA-DR+ CD8+ T-cells in twins indicate a 50% risk of progression to type I diabetes by life-table analysis (P = 0.01), with a positive predictive value of 100%, sensitivity of 50%, and specificity of 100%. Elevated CD25+ T-cell levels in prediabetic and low-risk twins were less marked and less able to discriminate between the twin groups.
CONCLUSIONS
These results demonstrate that prediabetes is characterized by persistent elevation of HLA-DR+ CD8+ T-cells with the same cytotoxic phenotype as cells predominating in the islet at diagnosis, suggesting that the circulating cells may have a role in the pathogenesis of islet damage.
American Diabetes Association
Title: Persistent Activation of CD8+ T-cells Characterizes Prediabetic Twins
Description:
OBJECTIVE
Elevated circulating levels of activated CD3+ T-cells are characteristic of type I diabetes at diagnosis, and activated CD8+ (cytotoxic/suppressor) T-cells predominate in the islet infiltrate.
The aim of this study was to examine the peripheral blood of prediabetic and nondiabetic identical twins of patients with type I diabetes for the presence of activated CD8+ T-cells and by comparing these groups, analyze the relationship of such cells to the development of the disease.
RESEARCH DESIGN AND METHODS
In a 10-year prospective study, blood T-cell subsets (CD3+ total T-cells, CD4+ helper/inducer, and CD8+ cytotoxic/suppressor) were analyzed for evidence of activation (cell surface expression of HLA-DR, CD25) in 18 identical twins of patients with type I diabetes, 8 of whom became diabetic (prediabetic twins), while 10 remained nondiabetic after at least 8 years of follow-up and are now at low risk for type I diabetes.
Fifteen healthy individuals were studied as control subjects.
RESULTS
At the beginning and during the study, percentage levels of activated CD3+ HLA-DR+ T-cells were significantly elevated in prediabetic and low-risk twins compared with control subjects (P < 0.
005) but remained high only in prediabetic twins (P < 0.
005).
Both prediabetic and low-risk twins had elevated levels of HLA-DR+ CD4+ T helper cells compared with control subjects throughout the study (P < 0.
001), and these remained high in both (P < 0.
001 and P < 0.
05, respectively).
Only prediabetic twins had elevated levels of HLA-DR+ CD8+ T-cells during the study.
These were significantly higher than in control subjects (P < 0.
005) and low-risk twins (P < 0.
05) and remained persistently elevated to diagnosis (P < 0.
001).
Abnormally elevated levels of HLA-DR+ CD8+ T-cells in twins indicate a 50% risk of progression to type I diabetes by life-table analysis (P = 0.
01), with a positive predictive value of 100%, sensitivity of 50%, and specificity of 100%.
Elevated CD25+ T-cell levels in prediabetic and low-risk twins were less marked and less able to discriminate between the twin groups.
CONCLUSIONS
These results demonstrate that prediabetes is characterized by persistent elevation of HLA-DR+ CD8+ T-cells with the same cytotoxic phenotype as cells predominating in the islet at diagnosis, suggesting that the circulating cells may have a role in the pathogenesis of islet damage.
Related Results
Oligoclonal Expansion of Effector Memory CD8+CD57+ T Cells May Sustain Bone Marrow Destruction in Aplastic Anemia
Oligoclonal Expansion of Effector Memory CD8+CD57+ T Cells May Sustain Bone Marrow Destruction in Aplastic Anemia
Abstract
The character of oligoclonal expansion of CD8+CD28- lymphocytes in aplastic anemia (AA), described by Risitano et al. (Blood, 2002 and Lancet, 2004), strong...
The role of CD8+ T cells in the immunoregulation of osteoporosis
The role of CD8+ T cells in the immunoregulation of osteoporosis
Introduction
Osteoporosis weakens the skeleton by lowering bone mass and damaging bone microarchitecture. A growing body of evidence poin...
Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients
Genome-Wide DNA Methylation Analysis Identifies Aberrant Epigenetic Changes in CD8+ T Cells from Chronic Lymphocytic Leukemia Patients
Abstract
Background CD8+ T cells from chronic lymphocytic leukemia (CLL) patients have been demonstrated to exhibit a number of alterations in global gene expression...
T cell specific Eomes Deletion Does Not Protect Against High Fat Diet Induced Large Artery Stiffening
T cell specific Eomes Deletion Does Not Protect Against High Fat Diet Induced Large Artery Stiffening
We have found that T cells contribute to age-related large artery stiffness. The T-box transcription factor, Eomes is an important regulator of CD8+ (Cytotoxic) T cell differentiat...
Exploring the possible mechanism of low-dose naloxone exposure improving the immune microenvironment of gastric cancer tumors
Exploring the possible mechanism of low-dose naloxone exposure improving the immune microenvironment of gastric cancer tumors
IntroductionGastric cancer, one of the most common cancers of the digestive tract, has high incidence and mortality rates. Until recently, surgery has been the most effective metho...
Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells
Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells
Abstract
In this study, we have investigated the basic requirements for HIV-1 infection of CD8+ lymphocytes in vitro. Unfractionated PBL obtained from healthy HIV-1 ...
Clinical and Immunometabolic Patterns Determining Efficacy of DCtreatment reinvigorating HIV-1-specific CD8+ T cells in PLWH
Clinical and Immunometabolic Patterns Determining Efficacy of DCtreatment reinvigorating HIV-1-specific CD8+ T cells in PLWH
Introduction: Heterogeneous dysfunctional states of CD8+ T cells in people living with HIV-1 (PWLH) has limited the efficacy of dendritic cell (DC)-based immunotherapies. Here, we ...
Imbalance between CD8
+
CD28
+
and CD8
+
CD28
–
T-cell subsets and its clinical significance in
Imbalance between CD8
+
CD28
+
and CD8
+
CD28
–
T-cell subsets and its clinical significance in
Objective
The aim of this study was to evaluate the changes in CD8
+
CD28
...

